当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析 - 现金流量表

威尔药业

(603351)

  

流通市值:36.73亿  总市值:36.73亿
流通股本:1.35亿   总股本:1.35亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金249,896,152.111,135,771,763.99828,431,121.96526,557,305.31
  收到的税费返还2,724,054.5312,819,014.059,730,464.087,878,432.1
  收到其他与经营活动有关的现金2,877,052.116,543,019.567,458,148.155,864,565.04
  经营活动现金流入小计255,497,258.751,155,133,797.6845,619,734.19540,300,302.45
  购买商品、接受劳务支付的现金152,541,659.62605,965,686.12497,021,447.24308,224,270.74
  支付给职工以及为职工支付的现金58,403,376.27141,871,979.5112,307,545.6382,961,898.87
  支付的各项税费16,053,632.379,477,421.9657,821,472.3736,731,084.29
  支付其他与经营活动有关的现金11,300,605.2189,573,774.4334,689,071.1938,108,431.13
  经营活动现金流出小计238,299,273.4916,888,862.01701,839,536.43466,025,685.03
  经营活动产生的现金流量净额17,197,985.35238,244,935.59143,780,197.7674,274,617.42
二、投资活动产生的现金流量:
  收回投资收到的现金-13,875,137.27--
  取得投资收益收到的现金-24,989.1515,380.18-
  处置固定资产、无形资产和其他长期资产收回的现金净额-223,484.62--
  收到的其他与投资活动有关的现金100,000-900,000900,000
  投资活动现金流入小计100,00014,123,611.04915,380.18900,000
  购建固定资产、无形资产和其他长期资产支付的现金14,125,404.0852,179,557.3749,482,846.9739,197,235.08
  投资支付的现金5,000,00036,000,00033,000,00033,000,000
  支付其他与投资活动有关的现金--600,000600,000
  投资活动现金流出小计19,125,404.0888,179,557.3783,082,846.9772,797,235.08
  投资活动产生的现金流量净额-19,025,404.08-74,055,946.33-82,167,466.79-71,897,235.08
三、筹资活动产生的现金流量:
  取得借款收到的现金200,000,000551,000,000421,000,000309,000,000
  筹资活动现金流入小计200,000,000551,000,000421,000,000309,000,000
  偿还债务支付的现金181,000,000461,320,400291,800,000239,800,000
  分配股利、利润或偿付利息支付的现金3,479,085.9864,888,778.7262,127,676.8960,027,865.22
  支付其他与筹资活动有关的现金2,228,909.2511,487,056.658,538,580.854,825,434.93
  筹资活动现金流出小计186,707,995.23537,696,235.37362,466,257.74304,653,300.15
  筹资活动产生的现金流量净额13,292,004.7713,303,764.6358,533,742.264,346,699.85
四、汇率变动对现金及现金等价物的影响-1,868,455.15-828,047.87780.95342,762.81
五、现金及现金等价物净增加额9,596,130.89176,664,706.02120,147,254.187,066,845
  加:期初现金及现金等价物余额423,865,188.4247,200,482.38247,200,482.38247,200,482.38
  期末现金及现金等价物余额433,461,319.29423,865,188.4367,347,736.56254,267,327.38
补充资料:
  净利润-148,987,071.3-71,302,630.46
  资产减值准备-6,031,196.28-2,467,637.19
  固定资产和投资性房地产折旧-118,503,969.25-59,616,498.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-118,503,969.25-59,616,498.13
  无形资产摊销-4,858,741.16-2,423,086.46
  长期待摊费用摊销-251,734.7-36,334.29
  处置固定资产、无形资产和其他长期资产的损失--16,250.03--6,484.57
  固定资产报废损失-422,240.97-90,420.98
  公允价值变动损失--3,413,109.64--1,736.22
  财务费用-11,509,279.77-5,613,022.4
  投资损失--24,989.15--
  递延所得税-3,590,369.63-949,858.45
  其中:递延所得税资产减少-2,010,121.38-451,587.74
    递延所得税负债增加-1,580,248.25-498,270.71
  存货的减少--10,120,648.95--11,785,019.22
  经营性应收项目的减少--414,811,189.1--78,285,739.97
  经营性应付项目的增加-365,188,350.8-16,663,396.16
  其他--2,429,607.96--
  不涉及现金收支的投资和筹资活动金额其他项目-52,397,400.62--
  现金的期末余额-423,865,188.4-254,267,327.38
  减:现金的期初余额-247,200,482.38-247,200,482.38
  现金及现金等价物的净增加额-176,664,706.02-7,066,845
公告日期2026-04-282026-04-282025-10-302025-08-20
审计意见(境内)标准无保留意见
TOP↑